Wolverine Trading, LLC Mirati Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $202,223 - $483,238	4,900 New	4,900 $222,000
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $117,479 - $266,130	3,000 Added 83.33%	6,600 $444,000
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $106,147 - $211,358	-1,400 Reduced 28.0%	3,600 $300,000
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $343,226 - $494,754	2,600 Added 108.33%	5,000 $741,000
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $79,278 - $106,470	600 Added 33.33%	2,400 $418,000
Q2 2021 Aug 06, 2021	BUY	$144.0 - $179.73 $259,200 - $323,514	1,800 New	1,800 $292,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.